Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Acrivastine adverse reaction |
Causative agent (attribute) |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to acrivastine |
Causative agent (attribute) |
False |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acrivastine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acrivastine+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing acrivastine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to acrivastine |
Causative agent (attribute) |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acrivastine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acrivastine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acrivastine 8 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
Has precise active ingredient |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acrivastine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only acrivastine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acrivastine and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acrivastine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acrivastine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |